Inhaltsübersicht

Publikationen

1. Afshar-Oromieh A, Haberkorn U, Eder M, Eisenhut M, Zechmann C. [(68)Ga]Gallium-labelled PSMA ligand as superior PET tracer for the diagnosis of prostate cancer: comparison with (18)F-FECH. Eur J Nucl Med Mol Imaging 2012;39:1085-1086.

2. Afshar-Oromieh A, Kratochwil C, Haberkorn U, Giesel FL. [Importance of PET/CT in lymphoma diagnostics]. Radiologe 2012;52(4):338-46.

3. Berger AK, von Gall C, Abel U, Delorme S, Kloor M, Ose J, Weber TF, Stange A, Haag GM, Haberkorn U, Lordick F, Jaeger D. A phase II study for metabolic in vivo response monitoring with sequential 18FDG-PET-CT during treatment with the EGFR-monoclonal-antibody cetuximab in metastatic colorectal cancer: the Heidelberg REMOTUX trial. BMC Cancer 2012;12(1):108. [Epub ahead of print].

4. Bierhaus A, Fleming T, Stoyanov S, Leffler A, Babes A, Neacsu C, Sauer SK, Eberhard M, Neuhuber WL, Kichko TI, Konrade I, Elvert R, Mier W, Pirags V, Lukic IK, Morcos M, Dehmer T, Rabbani N, Thornalley PJ, Edelstein D, Nau C, Forbes J, Schwaninger M, Stern DM, Cooper ME, Haberkorn U, Humpert PM, Brownlee M, Reeh PW, Nawroth PP. Methylglyoxal Modification of Nav1.8 Facilitates Nociceptive Neuron Firing and Causes Hyperalgesia. Nature Med 2012; [Epub ahead of print].

5. Breyer S, Semmler A, Miller T, Hill A, Geissler S, Haberkorn U, Mier W.Radioiodinated dechloro-4-iodofenofibrate: A hydrophobic model drug for molecular imaging studies. Int J Pharm 2012; [Epub ahead of print].

6. Dimitrakopoulou-Strauss A, Hohenberger H, Pan L, Kasper B, Roumia S, Strauss LG. Dynamic PET (dPET) with FDG in patients with unresectable aggressive fibromatosis: regression based parametric images and correlation to the FDG kinetics based on a two-tissue compartment model. Clin Nucl Med 2012; accepted.

7. Eder M, Schaefer M, Bauder-Wuest U, Hull WE, Wängler C, Mier W, Haberkorn U, Eisenhut M. The 68Ga-complex lipophilicity and the targeting property of a urea based PSMA inhibitor for PET imaging. Bioconjug Chem 2012; 23(4):688–697.

8. Giesel FL, Mehndiratta A, Mafomane MP, Zechmann CM, Bergmann F, Schemmer P, Haberkorn U, Kratochwil C. Cancer with unknown primary: finding a needle in a hay stack. Exp Oncol 2012;34(1):64-5.

9.Giesel FL, Mehndiratta A, Hempel A, Hempel E, Wuestenberg T, Kress KR, Essig M, Schröder J. Improvement of auditory hallucinations and reduction of primary auditory area's activation following TMS. Eur J Radiol 2012;81(6):1273-5.

10. Giesel FL, Kratochwil C, Wulfert S, Kauczor HU, Haberkorn H, Ley S. Comparison of Lesion Detection and Characterization in Patients with Neuroendocrine Tumors Using DOTATOC-PET in Correlation with Contrast-enhanced MRI and Contrast-enhanced CT. Eur J Radiol 2012; in print.

11. Giesel FL, Kratochwil C, Mehndiratta A, Wulfert S, Moltz JH, Zechmann CM, Kauczor HU, Haberkorn U, Ley S. Comparison of neuroendocrine tumor detection and characterization using DOTATOC-PET in correlation with contrast enhanced CT and delayed contrast enhanced MRI. Eur J Radiol 2012; [Epub ahead of print].

12. Kristen AV, Lehrke S, Buss S, Mereles D, Steen H, Ehlermann P, Hardt S, Giannitsis E, Schreiner R, Haberkorn U, Schnabel PA, Linke RP, Röcken C, Wanker EE, Dengler TJ, Altland K, Katus HA. Green tea halts progression of cardiac transthyretin amyloidosis: an observational report. Clin Res Cardiol 2012; [Epub ahead of print].

13. Lagemaat MW, Zechmann CM, Fütterer JJ, Weiland E, Lu J, Villeirs GM, Holshouser BA, van Hecke P, Lemort M, Schlemmer HP, Barentsz JO, Roell SO, Heerschap A, Scheenen TW. Reproducibility of 3D 1H MR spectroscopic imaging of the prostate at 1.5T. J Magn Reson Imaging 2012;35(1):166-73.

14. Raake PW, Schlegel P, Ksienzyk J, Reinkober J, Barthelmes J, Schinkel S, Pleger S, Mier W, Haberkorn U, Koch WJ, Katus HA, Most P, Müller OJ. AAV6.βARKct cardiac gene therapy ameliorates cardiac function and normalizes the catecholaminergic axis in a clinically relevant large animal heart failure model. Eur Heart J 2012; [Epub ahead of print].

15. Sarko D, Eisenhut M, Haberkorn U, Mier W. Bifunctional Chelators in the Design and Application of Radiopharmaceuticals for Oncological Diseases. Curr Med Chem 2012; [Epub ahead of print].

16. Strauss LG, Koczan D, Seiz M, Tuettenberg T, Schmieder K, Pan L, Cheng C, Dimitrakopoulou-Strauss A. Correlation of the Ga-68-Bombesin Analog Ga-68-BZH3 with Receptors Expression in Gliomas as Measured by Quantitative Dynamic Positron Emission Tomography (dPET) and Gene Arrays. Mol Imaging Biol 2012;14(3):376-83.

17. Takesh M, Haberkorn U, Strauss LG, Roumia S, Dimitrakopoulou-Strauss A. Incidental detection and monitoring of spontaneous recovery of sarcoidosis via fluorine-18-fluoroethyl-choline positron emission tomography/computed tomography. Hell J Nucl Med 2012; 15(1): 63-65.

18. Thiemann M, Oertel S, Ehemann V, Weichert W, Stenzinger A, Bischof M, Weber KJ, Lopez perez R, Haberkorn U, Kulozik A, Debus J, Huber PE, Battmann C. In vivo efficacy of the histone deacetylase inhibitor suberoylanilide hydroxamic acid in combination with radiotherapy in a malignant rhabdoid tumor mouse model. Radiation Oncology 2012;7: 52.

19. Zechmann CM, Traine L, Meißner T, Wagner-Gund B, Giesel FL, Goldschmidt H, Delorme S, Hillengass J. Parametric histogram analysis of dynamic contrast-enhanced MRI in multiple myeloma: A technique to evaluate angiogenic response to therapy ? Acad Radiol 2012;19:100-108.

20. Zechmann CM, Menze BH, Kelm BM, Zamecnik P, Ikinger U, Giesel FL, Thieke C, Delorme S, Hamprecht FA, Bachert P. Automated vs. Manual Pattern Recognition of 3D (1)H MRSI Data of Patients with Prostate Cancer. Acad Radiol 2012;19(6):675-84.

21. Zoller F, Schwaebel, T, Markert A, Haberkorn U, Mier W. Engineering and functionalization of the disulfide-constrained miniprotein Min-23 as a scaffold for diagnostic application. ChemMedChem 2012;7:237-247.

Buchbeiträge

1. Haberkorn U. Radiolabeled Drugs or the Use of Surrogate Biomarkers to Evaluate New Anticancer-Agents. In: Elsinga PH, van Waarde A, Paans AMJ, Dierckx RAJO. Trends on the Role of PET in Drug Development. World Scientific Publishing, New Jersey 2012, pp 447-505. ISBN 9789814317733.

2. Mehndiratta A, Knopp MV, Giesel FL. Magnetic Resonance Angiography: Review of Clinical Applications. In: Magnetic Resonance Angiography Basics to Future. Shabana W (ed.). InTech 2012. pp 23-38. ISBN 9789535104018.

3. Mehndiratta A, Prabu A, Kashyap R, Giesel FL. Acute Nutritional Emergencies. In: Emergency Medicine Manual (in print).

4. Mehndiratta A, Prabu A, Zechmann C, Giesel FL. Nuclear Medicine: An overview of Imaging Techniques, Clinical Applications and Trials. In: Therapeutic Specifics of Medical Imaging. Schwartz L (ed.). Springer (invited).

5. von Tengg-Kobligk H, Mehndiratta A, Giesel F. Contrast Agents in Radiology. In: Therapeutic Specifics of Medical Imaging. Schwartz L (ed.). Springer (invited).

6. Zechmann C. Kapitel Radiologie. In: Mediscript . Hammerexamen 10/2006 –10/2011 Alle Original-IMPP-Prüfungsfragen des 2. Abschnitts der Ärztlichen Prüfung, CD-Rom. Urban & Fischer bei Elsevier; 2012; ISBN 9783437330100.